[Humanized respiratory syncytial virus monoclonal antibody].
Copyright policy )[Humanized respiratory syncytial virus monoclonal antibody].
Respiratory syncytial virus remains a significant cause of severe lower respiratory tract disease in children. The risk of serious RSV illness is highest among children with prematurity, chronic lung disease and congenital heart disease. No effective vaccine and anti-viral agents have been obtained even now. Therefore, conservative therapy including respiratory aid has been a principal therapy for serious RSV disease. Recently, monthly intramuscular administration of humanized anti-RSV monoclonal antibody(palivizumab) was introduced in clinical fields in USA and Europe. Palivizumab prophylaxis has appeared to be safe and effective for prevention of serious RSV illness in premature children and those with bronchopulmonary dysplasia.
Clinical Trials as Topic, Infant, Newborn, Antibodies, Monoclonal, Infant, Respiratory Syncytial Virus Infections, Antibodies, Monoclonal, Humanized, Antibodies, Viral, Protein Engineering, Respiratory Syncytial Viruses, Mice, Treatment Outcome, Child, Preschool, Animals, Humans, Bronchopulmonary Dysplasia, Palivizumab
Clinical Trials as Topic, Infant, Newborn, Antibodies, Monoclonal, Infant, Respiratory Syncytial Virus Infections, Antibodies, Monoclonal, Humanized, Antibodies, Viral, Protein Engineering, Respiratory Syncytial Viruses, Mice, Treatment Outcome, Child, Preschool, Animals, Humans, Bronchopulmonary Dysplasia, Palivizumab
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!